Faron Pharmaceuticals Ends Traumakine Trial; Loss Narrows On Expenses
(Alliance News) - Faron Pharmaceuticals Oy on Monday said its loss narrowed considerably in the first half of 2019, after it cut back on research & development spending and opted to end a firm Read More